- Active not recruitingPHASE2
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
This study is testing a new combination of treatments for children and teenagers with a certain type of acute myeloid leukemia (FLT3-mutated AML). It combines a drug called midostaurin with standard chemotherapy to see if it's safe and effective for these patients.
For: FLT3-mutated Acute Myeloid LeukemiaCzechia · Germany · Italy - Active not recruitingPHASE2
Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients
This study looks at adding a new drug, midostaurin, to a standard treatment called decitabine for adults with certain types of blood cancers (AML or high-risk MDS). The goal is to see if this combination is safe and works better for patients who can't have intense chemotherapy.
For: AML/MDSBelgium · Germany · Netherlands